跳至主要内容
临床试验/NCT05810584
NCT05810584已完成不适用

A Retrospective and Prospective Clinical Study Evaluating Safety and Performance of Revision LR Stem in Total Hip Arthroplasty (THA)

Limacorporate S.p.a1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2021年6月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
试验地点
1
主要终点
Revision rate of the femoral component

研究概览

简要总结

This is a post-market, monocentric Retrospective and prospective, observational, open-label and baseline clinical study in order to evaluate the performance and safety of Revision LR femoral stem

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females of any race
  • Age ≥ 18 years old
  • A diagnosis or condition in the target hip of one or more of the following: Primary tumors or metastasis and relative outcomes; Advanced articular destruction generated by primary degenerative or post-traumatic arthrosis or rheumatoid arthritis;Fracture or avascular necrosis; Congenital or acquired deformity; Failures of previous operations, like osteosynthesis, articular reconstruction, arthrodesis, hemi-arthroplasty or total arthroplasty; Epiphyseal region general trauma, Willingness to comply with prescribed rehabilitation and study evaluation and ability to return for follow-up visits
  • Signed study-specific Informed Consent Form

排除标准

  • Acute or chronic infections, local or systemic infections,
  • Septicaemia
  • Persistent acute or chronic osteomyelitis
  • Serious muscular, neurological or vascular diseases affecting the concerned limb
  • Mass higher than 60 kg

结局指标

主要结局

Revision rate of the femoral component

时间窗: from baseline to FU 10 Years

Revision rate of the femoral component for aseptic loosening, not resultant from a tumor recurrence.

次要结局

  • Functionality evaluation(from baseline to FU 10 Years)
  • Incidence of device-related adverse events or serious adverse events.(from baseline to FU 10 Years)
  • Implant stability(from baseline to FU 10 Years)

研究者

发起方
Limacorporate S.p.a
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验